Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer

This publication has 64 references indexed in Scilit:

• Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study
  European Journal Of Cancer, 2000
• Lack of effect of small high-dose volumes on the dose–response relationship for the development of fibrosis in distant parts of the ipsilateral lung in mini-pigs
  International Journal of Radiation Biology, 2000
• Hyperfractionated radiotherapy: Tops or flops?
  Medical and Pediatric Oncology, 1999
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
  Radiotherapy and Oncology, 1999
• Global cancer statistics
  CA: A Cancer Journal for Clinicians, 1999
• CHARTWEL-Bronchus (ARO 97-1)
  Strahlentherapie und Onkologie, 1997
• Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions
  International Journal of Radiation Biology, 1997
• Medically inoperable lung carcinoma: The role of radiation therapy
  Seminars in Radiation Oncology, 1996
• Definitive radiation therapy for medically inoperable patients with stage I and II non-small cell lung cancer
  Radiation Oncology Investigations, 1996
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992